Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

SILO logo
Silo Pharma
CM
CMCVentures
Community Contributor

Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s

Key Takeaways Silo Pharma is advancing a diversified pipeline of innovative therapies aimed at major health challenges in Central Nervous System (CNS) disorders like PTSD, fibromyalgia, Alzheimer’s, and multiple sclerosis (MS). The company’s unique approach of combining traditional drugs with psychedelic-inspired therapies positions it to address significant gaps in the treatment landscape.
View narrative
US$6.20
FV
86.8% undervalued intrinsic discount
234.00%
Revenue growth p.a.
7users have liked this narrative
0users have commented on this narrative
24users have followed this narrative
8 days ago author updated this narrative
DOCN logo
DigitalOcean Holdings
NE
Nenad
Community Contributor

DigitalOcean Will Grow 14% by Embracing AI with Paperspace Acquisition

1. Current Business (Present Narrative): DigitalOcean is a cloud computing provider focused on small and medium-sized businesses (SMBs) , startups, and developers.
View narrative
US$50.00
FV
42.8% undervalued intrinsic discount
18.62%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
22users have followed this narrative
4 months ago author updated this narrative

Community Investing Ideas

Load previous narratives
RACE logo
Ferrari
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts

New Electric Models And Flexible Production Will Boost Market Presence

Key Takeaways Expanded production and personalization options are expected to boost revenue and increase flexibility. Launch of new electric models and sustainability initiatives may enhance brand reputation and revenue growth.
View narrative
€435.48
FV
3.8% undervalued intrinsic discount
8.39%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
4 days ago author updated this narrative
OUT1V logo
Outokumpu Oyj
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts

Germany Production Centralization And Ferrochrome Focus Will Unlock Future Potential

Key Takeaways Centralizing production and cost-saving measures aim to improve profitability and enhance net margins by the targeted year. Growing demand for low-emission ferrochrome and possible U.S. tariff protections may boost revenue and market positioning.
View narrative
€3.58
FV
5.9% undervalued intrinsic discount
6.25%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
4 days ago author updated this narrative
YOU logo
YouGov
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts

SP3 Focus And Scandinavian Expansion Will Drive Success

Key Takeaways Commitment to SP3 strategy and AI enhancements suggest potential revenue growth and improved product offerings through technology and automation. Cost optimization and expansion into new regions indicate improved financial performance and market diversification potential.
View narrative
UK£5.61
FV
47.0% undervalued intrinsic discount
3.82%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
4 days ago author updated this narrative
UNI logo
Universal Store Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts

Perfect Stranger And Neovision Will Broaden Retail Opportunities

Key Takeaways Expansion of store network, with Perfect Stranger brand focus, aims to drive revenue growth through higher conversion rates than online sales. Increased private brand penetration and premium pricing strategies are expected to boost gross margins and earnings.
View narrative
AU$9.91
FV
20.7% undervalued intrinsic discount
9.96%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
4 days ago author updated this narrative
XRAY logo
DENTSPLY SIRONA
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts

Revamped E-commerce And Imaging Products Will Secure Success

Key Takeaways Strategic divestment of Wellspect HealthCare aims to unlock value and improve net margins, leveraging its growth and profitability. Focus on innovation and e-commerce in aligners and new product launches expects revenue growth and margin improvements in key segments.
View narrative
US$18.14
FV
26.3% undervalued intrinsic discount
-0.15%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
4 days ago author updated this narrative
MDGL logo
Madrigal Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts

FDA Approval Will Expand MASH Treatment Market Reach

Key Takeaways First FDA-approved MASH treatment and strong U.S. market launch position Madrigal Pharmaceuticals for significant revenue growth. Strategic team enhancements and international market expansion efforts could bolster efficiencies and enhance future net margins.
View narrative
US$417.60
FV
29.3% undervalued intrinsic discount
82.53%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
4 days ago author updated this narrative
CAPR logo
Capricor Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts

FDA Priority Review And NS Pharma Partnership Will Empower Deramiocel

Key Takeaways FDA priority review of deramiocel and partnership with NS Pharma could drive significant revenue growth and market penetration. Expanded manufacturing capabilities and milestone payments enhance financial position, supporting demand and potential future growth.
View narrative
US$43.71
FV
83.3% undervalued intrinsic discount
103.05%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
4 days ago author updated this narrative
HUN logo
Huntsman
AN
AnalystConsensusTarget
Consensus Narrative from 13 Analysts

North American And Chinese Production Will Fortify MDI Operations

Key Takeaways Tariffs reducing MDI imports may boost Huntsman's domestic production and revenue in North America. Cost recalibration and asset rationalization are expected to improve net margins by reducing operating expenses.
View narrative
US$17.08
FV
34.4% undervalued intrinsic discount
4.68%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
4 days ago author updated this narrative